Herbal extract shows promise in calming schizophrenia
NCT ID NCT07575516
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tested whether adding ashwagandha extract to standard schizophrenia medication (risperidone) could reduce inflammation and improve symptoms. 80 male patients took part. Researchers measured changes in a blood marker for inflammation (IL-1β) and used a standard symptom scale (PANSS) to track progress. The goal was to see if ashwagandha could be a helpful add-on therapy.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for NEUROINFLAMMATION are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
South Sulawesi Mental Hospital (RSKD Dadi)
Makassar, South Sulawesi, 90245, Indonesia
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Could talk therapy boost brain function in schizophrenia?
- Wisdom tooth study probes brain chemicals for clues to pain and anxiety
- Could an arthritis drug ease depression by calming brain inflammation?
- Herbal boost? ashwagandha may improve brain function in schizophrenia
- Talking back to voices: CBT shows promise for schizophrenia hallucinations
- Bee product boosts brain power in seniors? new study tests royal jelly